S&P 100
2.833,70
PKT
+97,68
PKT
+3,57
%
Werbung
Analysen zu S&P 100-Werten
Datum | Rating | Analyst | |
---|---|---|---|
21.12.12 | Halliburton kaufen | Deutsche Bank Securities | |
19.12.12 | Raytheon Technologies buy | Nomura | |
19.12.12 | FedEx neutral | Nomura | |
19.12.12 | Tesla neutral | JP Morgan Chase & Co. | |
19.12.12 | Starbucks buy | Jefferies & Company Inc. | |
19.12.12 | Citigroup strong buy | Raymond James Financial, Inc. | |
19.12.12 | Halliburton buy | Jefferies & Company Inc. | |
19.12.12 | Bank of America strong buy | Raymond James Financial, Inc. | |
19.12.12 | Intel underperform | Sanford C. Bernstein and Co., Inc. | |
18.12.12 | AT&T sector perform | RBC Capital Markets | |
18.12.12 | Amazon outperform | RBC Capital Markets | |
18.12.12 | Apple outperform | RBC Capital Markets | |
18.12.12 | Baxter International outperform | RBC Capital Markets | |
18.12.12 | Apple outperform | Pacific Crest Securities Inc. | |
18.12.12 | Boeing neutral | UBS AG | |
18.12.12 | Johnson Johnson buy | UBS AG | |
18.12.12 | Gilead Sciences buy | UBS AG | |
18.12.12 | Apple neutral | Citigroup Corp. | |
18.12.12 | Raytheon Technologies buy | Nomura | |
18.12.12 | Oracle hold | Jefferies & Company Inc. | |
18.12.12 | Apple outperform | Sanford C. Bernstein and Co., Inc. | |
17.12.12 | ConocoPhillips outperform | RBC Capital Markets | |
17.12.12 | Apple outperform | Robert W. Baird & Co. Incorporated | |
17.12.12 | Amgen outperform | RBC Capital Markets | |
17.12.12 | Oracle buy | Nomura | |
17.12.12 | Apple overweight | Piper Jaffray & Co. | |
17.12.12 | Amgen halten | Independent Research GmbH | |
17.12.12 | Honeywell overweight | Morgan Stanley | |
17.12.12 | Oracle underperform | Cheuvreux SA | |
17.12.12 | Oracle overweight | Morgan Stanley | |
17.12.12 | Apple buy | Jefferies & Company Inc. | |
17.12.12 | Nike equal-weight | Morgan Stanley | |
17.12.12 | CVS Health outperform | RBC Capital Markets | |
17.12.12 | Apple buy | Needham & Company, LLC | |
17.12.12 | 3M neutral | JP Morgan Chase & Co. | |
17.12.12 | Biogen buy | Goldman Sachs Group Inc. | |
14.12.12 | CVS Health buy | UBS AG | |
14.12.12 | Apple buy | UBS AG | |
14.12.12 | Apple overweight | Piper Jaffray & Co. | |
14.12.12 | Amgen neutral | Goldman Sachs Group Inc. |